Novo Nordisk

ESPEROCT

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ESPEROCT – J7204

Manufacturer:

Novo Nordisk

Name:

ESPEROCT

HCPCS Code Descriptor:

Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu

Category:

J Code

HCPCS:

J7204

NDC(s):

00169-8500-01, 00169-8200-01, 00169-8300-01, 00169-8150-01, 00169-8100-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

ESPEROCT is a Hematology drug manufactured by Novo Nordisk and administered via the Intravenous route of administration. The J Code: J7204 is aligned to the drug ESPEROCT.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/20

HCPCS Effective Date:

7/1/20

HCPCS Short Description:

Inj recombin esperoct per iu

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.mynovosecure.com/resources.html

ESPEROCT - J7204